SCHEMBL7748938

SCHEMBL7748938

Cc1[c]c(O)cc(O)n1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7400680 0.65
SCHEMBL33719 0.64
SCHEMBL7722362 0.64
SCHEMBL125608 0.64
SCHEMBL29287625 0.62 ACHE (0.43)
SCHEMBL4387508 0.59 PTPN1 (0.30)
SCHEMBL2432721 0.58
SCHEMBL91341 0.58
SCHEMBL1636770 0.58
SCHEMBL127356 0.58 KDM4E (0.37)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0932405-A4 IL-8 RECEPTOR ANTAGONISTS SMITHKLINE BECKMAN CORP (US) 2001-10-17 EP disclosed
US-6218539-B1 PHENYL UREAS SMITHKLINE BEECHAM CORPORATION 2001-04-17 US disclosed
EP-0939634-A4 IL-8 RECEPTOR ANTAGONISTS SMITHKLINE BEECHAM CORP (US) 2001-02-21 EP disclosed
US-6177448-B1 THERAPY FOR CHEMOKINE SENSITIVIE DISEASE SMITHKLINE BEECHAM CORPORATION 2001-01-23 US disclosed
WO-2000076508-A1 IL-8 RECEPTOR ANTAGONISTS SMITHKLINE BEECHAM CORPORATION (US) 2000-12-21 WO disclosed
EP-0939634-A1 IL-8 RECEPTOR ANTAGONISTS SMITHKLINE BEECHAM CORPORATION (US) 1999-09-08 EP disclosed
EP-0932405-A1 IL-8 RECEPTOR ANTAGONISTS SMITHKLINE BEECHAM CORPORATION (US) 1999-08-04 EP disclosed
WO-1998006398-A1 IL-8 RECEPTOR ANTAGONISTS SMITHKLINE BEECHAM CORPORATION (US) 1998-02-19 WO disclosed
WO-1997049400-A1 IL-8 RECEPTOR ANTAGONISTS SMITHKLINE BEECHAM CORPORATION (US) 1997-12-31 WO disclosed